Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00657) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Antimony
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Drug in Phase 2 Clinical Trial
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5354495"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Aldo-keto reductase 1B1 (AKR1B1) | DME Info | Homo sapiens | [1] | |||
| Estradiol 17-beta-dehydrogenase 2 (HSD17B2) | DME Info | Homo sapiens | [1] | |||
| Keto-steroid reductase (HSD17B7) | DME Info | Homo sapiens | [1] | |||
| DME(s) Induced by This Xenobiotics | ||||||
| Thioredoxin reductase TR1 (TXNRD1) | DME Info | Homo sapiens | [1] | |||
| Thymidylate synthase (TYMS) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | Classification of heavy-metal toxicity by human DNA microarray analysis. Environ Sci Technol. 2007 May 15;41(10):3769-74. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.